The agreement also provides Salus BioPharma with exclusivity for the production and marketing of pharma-grade cannabinoid products through MPX-operated dispensaries in Arizona, Maryland, Massachusetts and Nevada with a right of first refusal in any other U.S. State, other than California, … Read More
The post MPX Signs Agreement With Israeli Pharmaceutical Company Panaxia for the Production and … appeared first on Dagga Magazine.